 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Suven Pharma Standalone September 2023 Net Sales at Rs 224.62 crore, down 19.32% Y-o-Y

Suven Pharmaceuticals Ltd had reported a 12.2 percent year-on-year (YoY) rise in net profit at Rs 120.6 crore for the first quarter that ended June 30, 2023

Suven Pharma Q2 results: Net profit declines 5.3% YoY to Rs 74.72 crore

The price offered of Rs 495 to public shareholders is at a discount of Rs 79 to the current market price.

Suven Pharma trades 2% up on open offer for 6.61 crore shares

The approval is for the acquisition of up to 76.1 percent stake in Suven Pharmaceuticals by Cyprus-based Berhyanda Ltd.

Suven Pharma soars 6% as cabinet committee greenlights Rs 9,589 crore FDI deal

Suven Pharma Consolidated June 2023 Net Sales at Rs 347.55 crore, up 2.58% Y-o-Y

Suven Pharma Standalone June 2023 Net Sales at Rs 344.03 crore, up 1.54% Y-o-Y

The company reported net profit of Rs 107 crore during the same period a year ago

Suven Pharma Q1 net profit rises 12.12% to Rs 120.5 crore

Suven Pharma Standalone March 2023 Net Sales at Rs 364.39 crore, up 0.15% Y-o-Y

Suven Pharma Consolidated March 2023 Net Sales at Rs 369.36 crore, up 1.51% Y-o-Y

Suven Pharma Standalone December 2022 Net Sales at Rs 348.49 crore, down 11.01% Y-o-Y

Suven Pharmaceuticals Ltd. manufactures chemical products. It specializes in providing pharmaceutical solutions to global life science companies. The firm engages in Contract Research & Manufacturing Services (CRMS) business where research and development is customized to the needs of global pharmaceutical customers. Its business segments include pharmaceutical solutions, active pharma ingredients, intermediates and formulations. The company was founded on November 6, 2018 and is headquartered in Hyderabad, Telangana.

Watchers	39
52-Wk Low	456.00
52-Wk High	683.00

Market Cap	171.6B
Volume (M)	387,978.00
52-Wk High	683.00
52-Wk Low	456.00

SUVENPHAR.NSE Suven Pharmaceuticals Ltd.

About

Feed

News

Sentiment

Fundamentals